COUNSELLING: EICF is a soft marker for chromosomal abnormalities especially trisomy 21. However it does not increase the risk over background risk. This can further be modified by serum screening(quadruple test) which is advised to the patient. Quadruple test has sensitivity of around 70% for trisomy 21. Availability of screening test with >99% sensitivity for trisomy 21 ie NIPT has been explained to the couple. Amniocentesis remains to be the diagnostic test for aneuploidies. + In absence of aneuploidies, EICF is a benign marker and does not adversely affect cardiac functiom help me